Carrie Dawn Deshong, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 525 Fulton Drive, Mcconnellsburg, PA 17233 Phone: 717-485-3850 Fax: 717-485-3725 |
Abagael Marie Boehme, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 214 Peach Orchard Road, Mcconnellsburg, PA 17233 Phone: 717-485-3155 |
News Archive
Collaboration between the National University of Singapore (NUS) and The Hebrew University of Jerusalem (HUJ) on inflammation research may lead to a potential treatment for deadly bacterial infections
More than 1 million Kenyans living in prolonged drought conditions are not getting the food aid they need, Gabrielle Menezes, a spokeswoman for the U.N.'s World Food Program (WFP), said recently, the Associated Press reports. She said WFP already provides emergency food aid to about 2.5 million people in Kenya, but another 1.3 million still need help.
July 3 was the quiet afternoon that a deputy assistant Treasury secretary for tax policy announced in a blog post that the Affordable Care Act's employer mandate would be delayed one year. Something about the "complexity of the requirements." ... Even if you are a liberal and support the goals of the Affordable Care Act, there has to be an emerging sense that maybe the law's theorists missed a signal from life outside the castle walls. While they troweled brick after brick into a 2,000-page law, the rest of the world was reshaping itself into smaller, more nimble units whose defining metaphor is the 140-character Twitter message (Daniel Henninger, 7/10).
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
MAP Pharmaceuticals, Inc. today announced that LEVADEX orally inhaled migraine drug will be featured in four poster presentations, including one late-breaker presentation, at the 15th Congress of the International Headache Society (IHC) in Berlin, Germany on June 23-26, 2011.
› Verified 7 days ago